Imaging techniques for local recurrence of prostate cancer: for whom, why and how?

O Rouvière

doi:10.1016/j.diii.2012.01.012

Imaging techniques for local recurrence of prostate cancer: for whom, why and how?

Diagn Interv Imaging. 2012 Apr;93(4):279-90. doi: 10.1016/j.diii.2012.01.012. Epub 2012 Mar 30.

Author

O Rouvière¹

Affiliation

¹ Department of Urinary and Vascular Imaging, hospices civils de Lyon, hôpital Édouard-Herriot, 5, place d'Arsonval, 69437 Lyon, France. [email protected]

PMID: 22464995
DOI: 10.1016/j.diii.2012.01.012

Abstract

Since there are salvage solutions, it is important to detect local recurrence of prostate cancer as early as possible. The first sign is "biochemical failure" in that the prostate specific antigen (PSA) concentration rises again. The definition of biochemical failure varies depending on the initial treatment: PSA greater than 0.2ng/mL after prostatectomy, nadir+2ng/mL after radiotherapy. There is no standardised definition of biochemical failure after cryotherapy, focused ultrasound, or brachytherapy. Magnetic resonance imaging (MRI) (particularly dynamic MRI) can detect local recurrence with good sensitivity. The role of spectroscopy is still under discussion. For the moment, ultrasound techniques are less effective than MRI.

Publication types

Case Reports
Review

MeSH terms

Aged
Humans
Magnetic Resonance Imaging*
Male
Middle Aged
Neoplasm Recurrence, Local / diagnosis*
Neoplasm Recurrence, Local / diagnostic imaging
Prostatic Neoplasms / diagnosis*
Prostatic Neoplasms / diagnostic imaging
Prostatic Neoplasms / therapy
Ultrasonography